4.5 Article

Angiotensin II receptor antagonists against migraine in pregnancy: fatal outcome

Journal

JOURNAL OF HEADACHE AND PAIN
Volume 11, Issue 2, Pages 167-169

Publisher

SPRINGER
DOI: 10.1007/s10194-009-0182-7

Keywords

Migraine; Pregnancy; Fetotoxic medication; Angiotensin II receptor antagonist; Angiotensin-converting enzyme inhibitor; Hypertension

Ask authors/readers for more resources

A pregnant young woman with a severe migraine is prescribed candesartan, an angiotensin II type 1 receptor antagonist (AT II antagonists). This has a positive effect-except for severe maldevelopment of her fetus. There is an increase in the use of the fetotoxic drugs, AT II antagonists and angiotensin-converting enzyme inhibitors, as prophylactic treatment of migraines, in addition to their use as hypertensives.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available